… trial) in primary progressive multiple sclerosis did not meet its … in patients with primary
progressive multiple sclerosis. Here, we … in patients with primary progressive multiple sclerosis. …

… for progressive forms of multiple sclerosis. … progressive MS will require an integrated,
multi-disciplinary approach to enable effective translation of research into therapies for progressive …

… for the treatment of progressive forms of multiple sclerosis (MS) is a … on progressive MS,
future prospects for developing targeted therapeutics aimed at reducing disability in progressive …

… 15% of patients develop primary progressive multiple sclerosis (PPMS) … multiple sclerosis
(RRMS) but at a similar age when the conversion to secondary progressive multiple sclerosis (…

… Background The onset of secondary progression is a pivotal event in the course of
relapsing–remitting (RR) multiple sclerosis (MS). Patients with secondary progressive MS (SPMS) …

… multiple sclerosis, and the results of these studies remain inconclusive. No serial
neuropsychological data of an exclusively primary progressive … primary progressive multiple …

… , collectively referred to as progressive MS, has proven quite … of multiple sclerosis in general,
specifically that of progressive … differences between relapsing and progressive forms of MS, …

… pathology, and immunology between the relapsing and progressive stages of multiple
sclerosis. The data suggest that both the relapsing and the progressive stages of MS are driven by …

… Survival analysis curves for progression of disability in patients with primary progressive
multiple sclerosis. The times required to progress to the need for unilateral gait assistance (…

Chronic progressive multiple sclerosis (MS) is a severely disabling demyelinating disease in
which autoimmune processes seem to have a major role. The nucleoside drug cladribine is …